Known targets — ChEMBL curated mechanism
AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA
The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15715909 | 0.90 | TSHR (0.39) | — | |
| SCHEMBL6239750 | 0.90 | TSHR (0.39) | — | |
| SCHEMBL863801 | 0.90 | TSHR (0.39) | — | |
| Lithium Ion SCHEMBL4301067 | 0.90 | — | — | |
| SCHEMBL4879181 | 0.90 | — | — | |
| SCHEMBL6302277 | 0.82 | TSHR (0.33) | — | |
| SCHEMBL17422887 | 0.82 | TSHR (0.33) | — | |
| SCHEMBL8214546 | 0.73 | TSHR (0.35) | — | |
| Potassium Ion SCHEMBL5342298 | 0.70 | — | — | |
| Potassium Ion SCHEMBL5342292 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022111564-A1 | RACEMIZATION METHOD FOR AND USE OF PYRIDINE DERIVATIVE | 海南凯菲士企业管理合伙企业（有限合伙） | 2022-06-02 | — | — | WO | claimed |
| EP-1690879-B1 | transparent, impact-resistant polystyrene on a styrene-butadiene block copolymer basis | BASF SE (DE) | 2008-08-20 | — | — | EP | claimed |
| EP-1171497-B1 | TRANSPARENT, IMPACT-RESISTANT POLYSTYRENE ON A STYRENE-BUTADIENE BLOCK COPOLYMER BASIS | BASF AG (DE) | 2006-10-11 | — | — | EP | claimed |
| EP-1690879-A1 | transparent, impact-resistant polystyrene on a styrene-butadiene block copolymer basis | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-16 | — | — | EP | claimed |
| US-6593430-B1 | Anionic polymerization in presence of potassium salt | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-15 | — | — | US | claimed |
| EP-1171497-A1 | TRANSPARENT, IMPACT-RESISTANT POLYSTYRENE ON A STYRENE-BUTADIENE BLOCK COPOLYMER BASIS | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-16 | — | — | EP | claimed |
| WO-2000058380-A1 | TRANSPARENT, IMPACT-RESISTANT POLYSTYRENE ON A STYRENE-BUTADIENE BLOCK COPOLYMER BASIS | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-05 | — | — | WO | claimed |
| US-12448346-B1 | Catalytic method for acrylate production | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-10-21 | — | — | US | disclosed |
| EP-4374877-A2 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2024-05-29 | — | — | EP | disclosed |
| EP-3928779-B1 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2024-03-06 | — | — | EP | disclosed |
| US-11834538-B2 | Anionic graft polymerization onto an existing polymer chain by organometallic base activation | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2023-12-05 | — | — | US | disclosed |
| WO-2022111564-A1 | RACEMIZATION METHOD FOR AND USE OF PYRIDINE DERIVATIVE | 海南凯菲士企业管理合伙企业（有限合伙） | 2022-06-02 | — | — | WO | disclosed |
| EP-3928779-A1 | PHARMACEUTICAL CONTAINING SODIUM-DEPENDENT PHOSPHATE TRANSPORTER INHIBITOR AND PHOSPHORUS ADSORBENT FOR USE IN THE PREVENTION, TREATMENT OR SUPPRESSION OF CHRONIC KIDNEY DISEASE, ARTERIOSCLEROSIS ASSOCIATED WITH VASCULAR CALCIFICATION, OR ECTOPIC CALCIFICATION. | Chugai Seiyaku Kabushiki Kaisha (JP) | 2021-12-29 | — | — | EP | disclosed |
| US-20060128890-A1 | Transparent mixtures of linear styrene-butadiene block copolymers | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-15 | — | — | US | disclosed |
| EP-1669407-A1 | Transparent mixtures of linear styrene-butadiene-blockcopolymers | BASF AKTIENGESELLSCHAFT (DE) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005118663-A1 | TRANSPARENT MIXTURES OF STYRENE-BUTADIENE BLOCK COPOLYMERS AND POLYSTYRENE | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-15 | — | — | WO | disclosed |
| WO-2005005536-A1 | BLENDS OF GRAFT COPOLYMERS AND STYRENE/BUTADIENE BLOCK COPOLYMERS | BASF AKTIENGESELLSCHAFT (DE) | 2005-01-20 | — | — | WO | disclosed |
| US-6593430-B1 | Anionic polymerization in presence of potassium salt | BASF AKTIENGESELLSCHAFT (DE) | 2003-07-15 | — | — | US | disclosed |
| EP-1171497-A1 | TRANSPARENT, IMPACT-RESISTANT POLYSTYRENE ON A STYRENE-BUTADIENE BLOCK COPOLYMER BASIS | BASF AKTIENGESELLSCHAFT (DE) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000058380-A1 | TRANSPARENT, IMPACT-RESISTANT POLYSTYRENE ON A STYRENE-BUTADIENE BLOCK COPOLYMER BASIS | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-05 | — | — | WO | disclosed |